The decrease in adiponectin level and the increase in DNA methylation levels in the adiponectin promoter region may be important factors in accelerating the progression of non-alcoholic fatty liver disease (NAFLD). Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.